
Volveria-LF Tablet
Marketer
Osiante Biotech
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Volveria-LF Tablet
Malarone-LF tablets treat malaria in adults and children. This medication combines two antimalarial drugs. It's not for malaria prevention or severe cases impacting vital organs (brain, lungs, kidneys). Malarone-LF works by eliminating the malaria parasite, halting infection spread. Always take it with food to optimize absorption. Follow your doctor's prescribed dosage and duration precisely; exceeding it can be harmful. Complete the entire course for effective treatment. Common side effects include headache, appetite loss, fatigue, and muscle or joint pain; dizziness is also possible. Report persistent or worsening side effects to your physician. Disclose all other medications to your doctor before starting Malarone-LF. Pregnant or nursing individuals should only use this medication under strict medical supervision due to potential harm to the fetus or infant.
Uses of Volveria-LF Tablet
Managing Malaria Infection
Major Benefits of Volveria-LF Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Volveria-LF Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Volveria-LF Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Volveria-LF Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Volveria-LF Tablet with a meal.
How Volveria-LF Tablet works:
Artemether and lumefantrine, the active components of Volveria-LF Tablet, offer a dual-action approach to malaria treatment. Their combined effect elevates blood heme concentrations, a substance harmful to the malaria parasite. This elevated heme level leads to parasite death and halts disease progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Volveria-LF Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Volveria-LF Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Medical advice is recommended.
Breast feedingSAFE IF PRESCRIBED
Use of Volveria-LF Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Volveria-LF Tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Volveria-LF Tablets cautiously. A physician should be consulted regarding potential dosage modifications for Volveria-LF Tablets. Dosage changes are not typically necessary for those with severe kidney disease.
LiverCAUTION
Patients with severe hepatic impairment should use Volveria-LF Tablets cautiously. A physician should be consulted regarding potential dose modifications for Volveria-LF Tablets in such cases. No dosage alteration is advised for those with severe liver disease.
What if you forget to take Volveria-LF Tablet :
Should you forget a Volveria-LF Tablet dose, administer it promptly. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Volveria-LF Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimalarial Drugs |
